Sökning: WFRF:(Onelov L) > The choice between ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03412naa a2200349 4500 | |
001 | oai:gup.ub.gu.se/45662 | |
003 | SwePub | |
008 | 240528s2006 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:1942240 | |
024 | 7 | a https://gup.ub.gu.se/publication/456622 URI |
024 | 7 | a https://doi.org/10.1016/j.eururo.2005.12.0382 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:19422402 URI |
040 | a (SwePub)gud (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Hopfgarten, T.u Karolinska Institutet4 aut |
245 | 1 0 | a The choice between a therapy-induced long-term symptom and shortened survival due to prostate cancer |
264 | 1 | b Elsevier BV,c 2006 |
520 | a OBJECTIVES: A patient with newly diagnosed localized prostate cancer can choose from an array of therapies. A patient's willingness to trade life for freedom from therapy-induced long-term symptoms is poorly investigated. METHODS: In October 2002, we attempted to collect information from the 591 men who had been diagnosed and registered with prostate cancer in 1999 in Stockholm County. In a postal questionnaire, men were asked to balance absence or presence of certain therapy-induced long-term symptoms against varying lengths of survival gain as a consequence of the therapy. RESULTS: Information was provided by 511 (86%) of the 591 men. A large majority of the men participating in this study ended up in one of two extreme categories: either they accepted the therapy-induced symptom to gain survival or they did not. For fecal leakage, 78% of the men chose one of two extreme categories compared with 74% for urinary leakage, 71% for tender enlarged breasts, 73% for erectile dysfunction, and 78% for restricted diet. Thirty-seven percent of the men in the study were willing to accept fecal leakage if there was only the slightest chance to gain survival, comparing percentages for urinary leakage, tender enlarged breasts, restricted diet, and erectile dysfunction and were 48%, 53%, 55%, and 64%, respectively. CONCLUSION: Willingness to accept therapy-induced long-term symptoms to avoid a shortened survival due to prostate cancer varies dramatically among men with localized prostate cancer and a large majority of men are in one of two extreme categories. Among symptoms, long-term fecal leakage was the one fewest men were willing to accept to gain survival. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
700 | 1 | a Adolfsson, J.u Karolinska Institutet4 aut |
700 | 1 | a Henningsohn, L.u Karolinska Institutet4 aut |
700 | 1 | a Onelov, E.u Karolinska Institutet4 aut |
700 | 1 | a Steineck, Gunnar,d 1952u Karolinska Institutet,Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences4 aut0 (Swepub:gu)xstegu |
710 | 2 | a Karolinska Institutetb Institutionen för kliniska vetenskaper4 org |
773 | 0 | t Eur Urold : Elsevier BVg 50:2, s. 280-9q 50:2<280-9x 0302-2838 |
856 | 4 8 | u https://gup.ub.gu.se/publication/45662 |
856 | 4 8 | u https://doi.org/10.1016/j.eururo.2005.12.038 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:1942240 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy